FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1749156001> ?p ?o ?g. }

• W1749156001 endingPage "1247" @default.
• W1749156001 startingPage "1239" @default.
• W1749156001 abstract "Objective The objective of this study was to compare immunohistochemical profile for the apoptosis regulators p53, C-MYC, bax, PUMA, and PTEN and the cell cycle regulatory proteins p21 and p27, as well as clinical factors between types I and II tumors. Methods In total, 131 patients in FIGO (International Federation of Gynecology and Obstetrics) stages I-II were divided into 2 groups of patients after type I tumors (n = 79) and type II tumors (n = 52). Differences in the immunohistochemical profile for the cell cycle–related proteins, detected by tissue microarrays and immune-histochemistry, were compared. For statistical tests, the Pearson χ 2 test and the logistic regression model were used. All tests were 2-sided, and the level of statistical significance was P ≤ 0.05. Results In multivariate logistic regression analysis with recurrent disease as endpoint, FIGO stage (odds ratio [OR], 4.7), type I/II tumors (OR, 3.8), body mass index (BMI) (OR, 3.5), and p53 status (OR, 4.2) all were found to be independent predictive factors. In 2 different multivariate logistic regression analyses with type I/II tumors as endpoint, both p53 + p21 − (OR, 2.9) and p27 status (OR, 3.0) were associated with type II tumors. Differently, C-MYC status (OR, 0.4) was associated with type I tumors. Furthermore, age (OR, 1.04), BMI (OR, 0.4), and recurrent disease (OR, 4.3) all were associated to type II tumors. In survival analysis, there was a trend ( P = 0.054) toward better disease-free survival for patients with type I tumors. Conclusions Concomitant positivity for p53 and negativity for p21, positivity for p27, and negativity for C-MYC in an epithelial ovarian tumor might strengthen the diagnostic option of type II tumor ovarian carcinoma. Patients with type II tumors were older, had lower BMI, and had more often recurrent disease than patients with type I tumors." @default.
• W1749156001 created "2016-06-24" @default.
• W1749156001 creator A5044398019 @default.
• W1749156001 creator A5045140883 @default.
• W1749156001 creator A5063125058 @default.
• W1749156001 date "2015-09-01" @default.
• W1749156001 modified "2023-10-18" @default.
• W1749156001 title "Differences in Clinical and Biological Features Between Type I and Type II Tumors in FIGO Stages I-II Epithelial Ovarian Carcinoma" @default.
• W1749156001 cites W1546749513 @default.
• W1749156001 cites W1578826342 @default.
• W1749156001 cites W1961928411 @default.
• W1749156001 cites W1968212088 @default.
• W1749156001 cites W1972032673 @default.
• W1749156001 cites W1974756790 @default.
• W1749156001 cites W1980752656 @default.
• W1749156001 cites W2005619971 @default.
• W1749156001 cites W2008887283 @default.
• W1749156001 cites W2011065238 @default.
• W1749156001 cites W2019925311 @default.
• W1749156001 cites W2023414851 @default.
• W1749156001 cites W2027216206 @default.
• W1749156001 cites W2029764939 @default.
• W1749156001 cites W2038849147 @default.
• W1749156001 cites W2042277527 @default.
• W1749156001 cites W2049679161 @default.
• W1749156001 cites W2053263835 @default.
• W1749156001 cites W2058520631 @default.
• W1749156001 cites W2060151989 @default.
• W1749156001 cites W2070369494 @default.
• W1749156001 cites W2070386730 @default.
• W1749156001 cites W2087810003 @default.
• W1749156001 cites W2088429724 @default.
• W1749156001 cites W2090853702 @default.
• W1749156001 cites W2100030862 @default.
• W1749156001 cites W2100591504 @default.
• W1749156001 cites W2106724500 @default.
• W1749156001 cites W2110994269 @default.
• W1749156001 cites W2121741947 @default.
• W1749156001 cites W2129355295 @default.
• W1749156001 cites W2132855396 @default.
• W1749156001 cites W2136227540 @default.
• W1749156001 cites W2142296587 @default.
• W1749156001 cites W2153049425 @default.
• W1749156001 cites W2171981807 @default.
• W1749156001 cites W2331080960 @default.
• W1749156001 cites W4291982393 @default.
• W1749156001 doi "https://doi.org/10.1097/igc.0000000000000484" @default.
• W1749156001 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4549863" @default.
• W1749156001 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26035126" @default.
• W1749156001 hasPublicationYear "2015" @default.
• W1749156001 type Work @default.
• W1749156001 sameAs 1749156001 @default.
• W1749156001 citedByCount "8" @default.
• W1749156001 countsByYear W17491560012017 @default.
• W1749156001 countsByYear W17491560012018 @default.
• W1749156001 countsByYear W17491560012019 @default.
• W1749156001 countsByYear W17491560012020 @default.
• W1749156001 countsByYear W17491560012021 @default.
• W1749156001 countsByYear W17491560012023 @default.
• W1749156001 crossrefType "journal-article" @default.
• W1749156001 hasAuthorship W1749156001A5044398019 @default.
• W1749156001 hasAuthorship W1749156001A5045140883 @default.
• W1749156001 hasAuthorship W1749156001A5063125058 @default.
• W1749156001 hasBestOaLocation W17491560012 @default.
• W1749156001 hasConcept C121608353 @default.
• W1749156001 hasConcept C126322002 @default.
• W1749156001 hasConcept C142724271 @default.
• W1749156001 hasConcept C143998085 @default.
• W1749156001 hasConcept C146357865 @default.
• W1749156001 hasConcept C151730666 @default.
• W1749156001 hasConcept C151956035 @default.
• W1749156001 hasConcept C156957248 @default.
• W1749156001 hasConcept C193270364 @default.
• W1749156001 hasConcept C204232928 @default.
• W1749156001 hasConcept C38180746 @default.
• W1749156001 hasConcept C63363279 @default.
• W1749156001 hasConcept C65409693 @default.
• W1749156001 hasConcept C71924100 @default.
• W1749156001 hasConcept C86803240 @default.
• W1749156001 hasConceptScore W1749156001C121608353 @default.
• W1749156001 hasConceptScore W1749156001C126322002 @default.
• W1749156001 hasConceptScore W1749156001C142724271 @default.
• W1749156001 hasConceptScore W1749156001C143998085 @default.
• W1749156001 hasConceptScore W1749156001C146357865 @default.
• W1749156001 hasConceptScore W1749156001C151730666 @default.
• W1749156001 hasConceptScore W1749156001C151956035 @default.
• W1749156001 hasConceptScore W1749156001C156957248 @default.
• W1749156001 hasConceptScore W1749156001C193270364 @default.
• W1749156001 hasConceptScore W1749156001C204232928 @default.
• W1749156001 hasConceptScore W1749156001C38180746 @default.
• W1749156001 hasConceptScore W1749156001C63363279 @default.
• W1749156001 hasConceptScore W1749156001C65409693 @default.
• W1749156001 hasConceptScore W1749156001C71924100 @default.
• W1749156001 hasConceptScore W1749156001C86803240 @default.
• W1749156001 hasIssue "7" @default.
• W1749156001 hasLocation W17491560011 @default.
• W1749156001 hasLocation W17491560012 @default.
• W1749156001 hasLocation W17491560013 @default.

• next